Terms: = Sarcomas AND HIF1A, Q16665, 3091, ENSG00000100644, MOP1, HIF1-ALPHA, PASD8, HIF-1alpha AND Clinical Outcome
4 results:
1. Increased levels of hypoxia-inducible factor-1α are associated with Bcl-xL expression, tumor apoptosis, and clinical outcome in chondrosarcoma.
Chen C; Zhou H; Wei F; Jiang L; Liu X; Liu Z; Ma Q
J Orthop Res; 2011 Jan; 29(1):143-51. PubMed ID: 20661931
[TBL] [Abstract] [Full Text] [Related]
2. Correlation of hypoxic signalling to histological grade and outcome in cartilage tumours.
Boeuf S; Bovée JV; Lehner B; Hogendoorn PC; Richter W
Histopathology; 2010 Apr; 56(5):641-51. PubMed ID: 20459575
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of HIF-1a and its regulator, PHD2, in retroperitoneal sarcomas: clinico-pathologic implications.
Huang JH; Lee FS; Pasha TL; Sammel MD; Karakousis G; Xu G; Fraker D; Zhang PJ
Cancer Biol Ther; 2010 Feb; 9(4):303-11. PubMed ID: 20026900
[TBL] [Abstract] [Full Text] [Related]
4. Hypoxia in cancer: significance and impact on clinical outcome.
Vaupel P; Mayer A
Cancer Metastasis Rev; 2007 Jun; 26(2):225-39. PubMed ID: 17440684
[TBL] [Abstract] [Full Text] [Related]
